glp-1 regulatory news BREAKING 🚨 Comment “Beyond” for my full article with scientific references about why GLP-1s have health benefits beyond weight loss. 🏷️ #semaglutide #glp1 #fda #regulation GLP-1 Law & Policy

Learn why weight loss plateaus happen, what they mean, and the practical steps that can help you make progress again

The wholesaler shared that certain doses of medications continue to intermittently go out of stock

However, similar to other chronic diseases such as T2D, the focus in obesity management (including pharmacotherapy prescription) over time will need to be shifted to primary care and collaborative integrated care models to be developed between specialist obesity services and primary care striving to meet the needs of people living with obesity [115]

This will be a complete life change for anyone who needs that extra help and support in weight loss especially if you have tried everything and nothing seemed to work. The team was very helpful every step of the way

GLP-1 receptor agonists are recommended as either first-line or second-line therapy regardless of baseline hemoglobin A1c in patients who have established atherosclerotic cardiovascular disease, high risk of atherosclerotic cardiovascular disease, chronic kidney disease, or heart failure

This includes a thorough investigation into any hidden causes of weight gain while pairing medication with substantial, long-lasting lifestyle changes